MONTREAL, QUEBEC – Maisonneuve Rosemont, one of Montreal’s largest hospitals centres, has chosen iVision®, Retina Labs industry leading teleophthalmology and virtual care platform. iVision will be implemented to improve the level of service and efficiencies related to diabetic retinopathy screening. Diabetic retinopathy is one of the most common diabetic eye diseases and a leading cause of potentially irreversible vision loss.
iVision will allow the Maisonneuve Rosemont Hospital to greatly improve the community’s access to regular retinopathy screenings and the clinical accuracy of diagnoses. Diabetic retinopathy is a “silent” disease which often lurks without symptoms. People with diabetes should get a comprehensive retinal eye scan at least once a year. Early detection and timely treatment can reduce the risk of blindness by 95%. Unfortunately, due to backlogs in the public healthcare system and limited access to ophthalmologists, wait times are lengthy. Consequently, as many as 40% of diabetic patients do not get their eyes routinely scanned.
Through iVision’s enhanced ocular imaging technology, clinical interpretation tools, patient scheduling and automated recall, the Maisonneuve Rosemont Hospital will be able to ensure all patients receive access to annual scans with appropriate follow up and treatment.
“The Maisonneuve Rosemont Hospital is Canada’s leading ophthalmology and vision health centre,” states Hamid Fotuhi, General Manager of Retina Labs. “They are setting new standards and developing innovative best practices in the management of chronic eye diseases and we’re extremely pleased to play an important and vital role in their efforts,” concludes Fotuhi.
For over a decade, Retina Labs has been on the leading edge of telehealth and virtual care innovation. Its cloud-based iVision® teleophthalmology platform offers eye care professionals an integrated solution that combines advanced ocular imaging, clinical interpretation and reporting tools with integrated Electronic Medical Records, Practice Management and electronic referrals. The company’s solutions allow healthcare providers to improve access to quality eye care while streamlining the processes related to the management of chronic eye diseases such as diabetic retinopathy, glaucoma, age related macular degeneration and retinopathy of prematurity. iVision is the teleophthalmology platform of choice for hospitals, government health agencies and eye care professionals, and is recognized by the World Health Organization for its breakthrough advancements in telehealth technology. For more information on Retina Labs visit www.retina-labs.com.